You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Pocket Guide to IBD, Second Edition is designed to provide quick clinical information for gastroenterologists, primary care physicians, physician assistants, and nurse practitioners who need to review symptoms, medications, and disease management, in order to decide effective diagnoses and treatments for their patients with IBD. Some of the topics covered are:• Special populations, including pregnancy and children • Vaccinations in the patient with IBD • Treatment of the infliximab refractory patient • Diagnosis and treatment of perianal disease • Care of the post operative patient Dr. Marla Dubinsky and Dr. Sonia Friedman have created this go-to reference for one of the most popul...
Pocket Guide to IBD, Second Edition is designed to provide quick clinical information for gastroenterologists, primary care physicians, physician assistants, and nurse practitioners who need to review symptoms, medications, and disease management, in order to decide effective diagnoses and treatments for their patients with IBD. Some of the topics covered are: * Special populations, including pregnancy and children * Vaccinations in the patient with IBD * Treatment of the infliximab refractory patient * Diagnosis and treatment of perianal disease * Care of the post operative patient Dr. Marla Dubinsky and Dr. Sonia Friedman have created this go-to reference for one of the most popular topics...
IBD and the Elderly.
Ulcerative Colitis: The Complete Guide to Medical Management serves as the definitive source for medical management of ulcerative colitis (UC). Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with ulcerative colitis. Sections Include: • General o The role of the FDA in drug development; pediatric considerations; disease modifiers; and more • Medications o Antibiotic use in treatment of UC; oral novel biological therapies for UC; calcineurin inhibitors use in UC; novel biologic and non-biologic therapy...
Consult the leading text in the field that delivers the information you need to diagnose and treat pediatric gastrointestinal and liver diseases effectively. In one convenient and comprehensive volume, Drs. Robert Wyllie, Jeffrey S. Hyams, and Marsha Kay provide all the latest details on the most effective new therapies, new drugs, and new techniques in the specialty. In addition, the new two-color design throughout helps you find what you need quickly and easily. Full-color endoscopy images to help improve your visual recognition Definitive guidance from renowned international contributors who share their knowledge and expertise in this complex field Detailed diagrams that accurately illust...
Pediatric Inflammatory Bowel Disease, Second Edition provides an essential reference with an emphasis on the unique pediatric issues of IBD. Chapters focus on complications of IBD specific to children and adolescents. Treatment recommendations are based on the latest clinical research available. The textbook also presents sections dedicated to the aspects of participation in clinical research unique to children and adolescents and the complicated yet vital process of successfully transitioning a patient from a pediatric to adult specialist. Controversies in pediatric IBD care such as the off-label use of medications are also covered. The format incorporates multiple tables, graphs, and figur...
Pediatric Gastroenterology, An Issue of Pediatric Clinics of North America, E-Book
In this issue of Gastroenterology Clinics, guest editor Alan L. Buchman brings considerable expertise to the topic of Advances in Intestinal Transplantation. Experts in the field cover topics such as Indications for Intestinal Transplantation, Multivisceral Transplantation, and more. - Contains a variety of relevant topics including Normothermic Preservation of the Intestinal Allograft; Abdominal Wall Closure in Intestinal and Multivisceral Transplantation; Intestinal Transplant for Hirschsprung's Disease; and more. - Provides in-depth clinical reviews on intestinal transplantation, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Named one of the "Ten must-read science histories" by Science Magazine In a lifetime of practice, most physicians will never encounter a single case of PKU. Yet every physician in the industrialized world learns about the disease in medical school and, since the early 1960s, the newborn heel stick test for PKU has been mandatory in many countries. Diane B. Paul and Jeffrey P. Brosco’s beautifully written book explains this paradox. PKU (phenylketonuria) is a genetic disorder that causes severe cognitive impairment if it is not detected and treated with a strict and difficult diet. Programs to detect PKU and start treatment early are deservedly considered a public health success story. Some...
Inflammatory bowel diseases (IBD), are chronic and progressive diseases. Long-term complications are demolition surgery and colon-rectal cancer (CRC). A treat-to-target approach aims to modify the natural course of these diseases. Targets are pre-defined therapeutic goals demonstrated to prevent end-organ disfunction and disability in the long-term period. According to the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) indications, mucosal healing (MH) and clinical remission are the main targets in IBDs. Recently, the concept of remission and evidence on new targets included histological remission and transmural healing as future new targets. It remains controversial whether achieving these targets is associated with significantly better long-term disease outcomes. In this Research Topic, we aim to systematically review current evidence and future perspectives on therapeutic targets in IBD including mucosal and transmural healing.